{"name":"Xing Xie","slug":"xing-xie","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE16SkhpeUE0WDdiNjZkLTUwRktjYVhuZVpiemlQdG1uWFVmTjhxUDZtNDFHSVFEeWhNR2RadVJ3WTMxeVRNYjVRWV9ZWlN5SHZNNWYw?oc=5","date":"2026-03-02","type":"pipeline","source":"36 Kr","summary":"China Biopharmaceutical's Xie Xin: Medical IPOs to Diverge, Funds to Flow to Targets with Clear BD and Commercialization Prospects | 2026 Medical Industry Outlook - 36 Kr","headline":"China Biopharmaceutical's Xie Xin: Medical IPOs to Diverge, Funds to Flow to Targets with Clear BD and Commercialization","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBRNjNIZng3VTBhVVM2Qlh1dHJCNW10Z1RrX2d5YmVsZHVZYnRiY3VXUEZNR2VVajREanFaaVVYajVyVUVDeVU1ekhyQlF5S2dPV1RGUTA3QTh6Q1JvM2tr?oc=5","date":"2025-01-10","type":"pipeline","source":"Nature","summary":"Structural insights into the agonist activity of the nonpeptide modulator JR14a on C3aR | Cell Discovery - Nature","headline":"Structural insights into the agonist activity of the nonpeptide modulator JR14a on C3aR | Cell Discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1FWXYwZUdTcEJIY00wWE1JN2ZUb1U3OERyWTV3bkhjT3lrVUJrX3dJejEtMHpvTF9qazdyZmpSMzd4SEVwNzBmdEk5ZkVGN2REUUxJZm5JN0o4X1h1TUdR?oc=5","date":"2024-04-16","type":"pipeline","source":"Nature","summary":"Cryo-EM structures of adenosine receptor A - Nature","headline":"Cryo-EM structures of adenosine receptor A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5RX002S3oxZXdBYzZTYkdzS0JuQUJCSW1hQWdPa0Z2REM5aUZCTGRnY2QwSnBFVmViUzQtb0c2cGZnMENxWlZSV2lPSllVUV9MT1NjNUJzcUVuZ1dwMzRR?oc=5","date":"2024-02-14","type":"pipeline","source":"Nature","summary":"Operando investigation of the synergistic effect of electric field treatment and copper for bacteria inactivation - Nature","headline":"Operando investigation of the synergistic effect of electric field treatment and copper for bacteria inactivation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1uSWc5WEV3RnlOcGFhTi1WSnhFWUJpZzZPUEw4akxFM3V3dzdlT214UF9zQjh2SzdHNExPX3pZbWg0NVJOdW40aFI1Y1VXY1JCTjRyWEFhelc1WjFtZWJZ?oc=5","date":"2023-09-06","type":"trial","source":"Nature","summary":"Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials - Nature","headline":"Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1fTUhHSnJ0dWFlQ2l2UkhLMVZQNkhGLWZlcTV2VG1JTXRfUmxQeHdOZGhRTHFMenE2Mk5ya1U4blU0d2tNTklrNldRV1NPWnNLeVNiT3hGZWVmNHNKNlpv?oc=5","date":"2022-11-29","type":"pipeline","source":"Nature","summary":"IL6 supports long-term expansion of hepatocytes in vitro - Nature","headline":"IL6 supports long-term expansion of hepatocytes in vitro","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}